Hematology TimesNICE issues draft guideline for NHLFebruary 1, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesMutations could be therapeutic target for FLJanuary 5, 2016Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesEZH2 inhibitor can produce durable responsesDecember 31, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesTriplet disappoints in follicular lymphoma trialDecember 11, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesTrial of ofatumumab in FL stopped earlyNovember 25, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesCompanies abuse orphan drug designation, team saysNovember 23, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyRelated IssuesFollicular Lymphoma
Hematology TimesDrug ‘life-changing’ for CLL patients in phase 1 trialNovember 12, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesInhibitor exhibits ‘modest’ activity in lymphomaNovember 12, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsITC 2015: Review IDs features to aid thyroid lymphoma diagnosisNovember 10, 2015Rare DiseasesLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsNew therapies finding their place in management of follicular lymphomaNovember 5, 2015Indolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesReprogramming the immune systemNovember 1, 2015Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesRadiation often underused in follicular lymphomaOctober 23, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology NewsMedical Roundtable: The Changing Pharmacologic Treatment Landscape in Chronic Lymphocytic Leukemia October 20, 2015CLLFollicular Lymphoma
Hematology TimesBacterium may increase risk of DLBCL, FLOctober 14, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesVariations in blood cancer survival across EuropeSeptember 28, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
